Clinical trial · Observational
Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia
Prospective Cohort Study: Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective cohort study aims to assess the incidence of gastric cancer in patients with intestinal metaplasia in body of stomach or angular incisure. As secondary objectives, among the patients included in the cohort, the study will: * assess the incidence of low grade dysplasia, * assess the incidence of high grade dysplasia in patients with low grade dysplasia, * identify risk factors of progression to dysplasia and gastric cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Cancer | Malignant Gastric Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Incidence of gastric cancer or high grade dysplasia of the gastric mucosa
- timeFrame
- 3 years
- description
- Incidence of gastric cancer or high grade dysplasia of the gastric mucosa during the 3-year follow-up.
Secondary outcomes (2)
- measure
- Percentage of development of low grade dysplasia
- timeFrame
- 3 years
- description
- Percentage of development of low grade dysplasia in patients initially with intestinal metaplasia without dysplasia.
- measure
- Percentage of development of gastric cancer or high grade dysplasia
- timeFrame
- 3 years
- description
- Percentage of development in 3 years of gastric cancer or high grade dysplasia lesion, in patients initially with low grade dysplasia.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years. * Gastroscopic examination with biopsy in the 6 months preceding inclusion, with intestinal metaplasia in body of stomach or angular incisure. * Patient does not oppose to participate to the study. Exclusion Criteria: * Progressive concomitant disease with life expectancy less than 3 years. * Gastric cancer at the time of inclusion. * Patient with previous oesophageal cancer. * Patient with previous gastric surgery. * Anticipated obstacles to follow-up during the study (e.g., understanding difficulties, homelessness).
References
Publications (0)
Data not yet available